Company Filing History:
Years Active: 2018
Title: Haap Wolfgang: Innovator in Pharmaceutical Chemistry
Introduction
Haap Wolfgang is a notable inventor based in Loerrach, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have therapeutic applications.
Latest Patents
Wolfgang holds a patent for a compound known as 2,2,2-trifluoroethyl-thiadiazines. This invention provides a compound of formula (I) that exhibits BACE1 inhibitory activity. The active compounds are useful in the therapeutic and/or prophylactic treatment of conditions such as Alzheimer's disease. His innovative work in this area highlights the potential for new treatments for neurodegenerative diseases.
Career Highlights
Wolfgang is associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His role at the company has allowed him to focus on research and development, contributing to advancements in drug discovery and therapeutic solutions.
Collaborations
Wolfgang has collaborated with notable colleagues, including Lilli Anselm and Bjoern Bartels. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Haap Wolfgang's contributions to pharmaceutical chemistry, particularly through his patent on BACE1 inhibitors, demonstrate his commitment to advancing medical science. His work has the potential to impact the treatment of Alzheimer's disease significantly.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.